Scholar Rock Holding (SRRK) EPS (Basic) Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -19.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.20% |
| Dec 31, 2025 | -17.70% |
| Sep 30, 2025 | -17.84% |
| Jun 30, 2025 | 2.58% |
| Mar 31, 2025 | -47.21% |
| Dec 31, 2024 | 14.33% |
| Sep 30, 2024 | 13.51% |
| Jun 30, 2024 | 10.61% |
| Mar 31, 2024 | 8.09% |
| Dec 31, 2023 | 14.14% |
| Sep 30, 2023 | 12.46% |
| Jun 30, 2023 | 10.24% |
| Mar 31, 2023 | 5.47% |
| Dec 31, 2022 | -5.66% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -30.22% |
| Mar 31, 2022 | 20.63% |
| Dec 31, 2021 | -31.15% |
| Sep 30, 2021 | -32.35% |
| Jun 30, 2021 | 15.45% |
| Mar 31, 2021 | 37.94% |
| Dec 31, 2020 | 45.87% |
| Sep 30, 2020 | 40.23% |
| Jun 30, 2020 | 43.84% |